nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—TAOK1—blood plasma—bipolar disorder	0.0138	0.0304	CbGeAlD
Pazopanib—UGT1A1—urine—bipolar disorder	0.0113	0.0249	CbGeAlD
Pazopanib—LYN—blood plasma—bipolar disorder	0.011	0.0241	CbGeAlD
Pazopanib—MAP3K2—blood plasma—bipolar disorder	0.00802	0.0177	CbGeAlD
Pazopanib—FGF1—blood plasma—bipolar disorder	0.00756	0.0166	CbGeAlD
Pazopanib—FLT1—blood plasma—bipolar disorder	0.00662	0.0146	CbGeAlD
Pazopanib—SH2B3—adrenal cortex—bipolar disorder	0.00661	0.0145	CbGeAlD
Pazopanib—MAP3K9—thyroid gland—bipolar disorder	0.00652	0.0143	CbGeAlD
Pazopanib—STK10—blood plasma—bipolar disorder	0.00626	0.0138	CbGeAlD
Pazopanib—TAOK3—blood plasma—bipolar disorder	0.00624	0.0137	CbGeAlD
Pazopanib—UGT1A1—blood plasma—bipolar disorder	0.00592	0.013	CbGeAlD
Pazopanib—KDR—blood plasma—bipolar disorder	0.00559	0.0123	CbGeAlD
Pazopanib—MAP3K9—nervous system—bipolar disorder	0.00548	0.0121	CbGeAlD
Pazopanib—CSF1R—blood plasma—bipolar disorder	0.00546	0.012	CbGeAlD
Pazopanib—ITK—thyroid gland—bipolar disorder	0.00538	0.0118	CbGeAlD
Pazopanib—MAP3K9—cerebellum—bipolar disorder	0.00516	0.0113	CbGeAlD
Pazopanib—CYP1A2—urine—bipolar disorder	0.00502	0.011	CbGeAlD
Pazopanib—STK36—adrenal cortex—bipolar disorder	0.00497	0.0109	CbGeAlD
Pazopanib—KIT—blood plasma—bipolar disorder	0.00496	0.0109	CbGeAlD
Pazopanib—SLCO1B1—blood plasma—bipolar disorder	0.00492	0.0108	CbGeAlD
Pazopanib—PI4KB—adrenal cortex—bipolar disorder	0.0049	0.0108	CbGeAlD
Pazopanib—TAOK1—thyroid gland—bipolar disorder	0.00489	0.0108	CbGeAlD
Pazopanib—SH2B3—thyroid gland—bipolar disorder	0.00461	0.0101	CbGeAlD
Pazopanib—AURKC—thyroid gland—bipolar disorder	0.00454	0.00998	CbGeAlD
Pazopanib—FLT4—adrenal cortex—bipolar disorder	0.00432	0.0095	CbGeAlD
Pazopanib—PIP4K2C—adrenal cortex—bipolar disorder	0.0043	0.00945	CbGeAlD
Pazopanib—MAP3K9—brain—bipolar disorder	0.00419	0.00922	CbGeAlD
Pazopanib—TAOK1—nervous system—bipolar disorder	0.00412	0.00905	CbGeAlD
Pazopanib—STK16—thyroid gland—bipolar disorder	0.00392	0.00862	CbGeAlD
Pazopanib—SH2B3—nervous system—bipolar disorder	0.00388	0.00852	CbGeAlD
Pazopanib—TAOK1—cerebellum—bipolar disorder	0.00387	0.00852	CbGeAlD
Pazopanib—RIOK2—thyroid gland—bipolar disorder	0.00386	0.00848	CbGeAlD
Pazopanib—BMPR1B—thyroid gland—bipolar disorder	0.00382	0.0084	CbGeAlD
Pazopanib—AURKC—nervous system—bipolar disorder	0.00381	0.00839	CbGeAlD
Pazopanib—SH2B3—cerebellum—bipolar disorder	0.00365	0.00802	CbGeAlD
Pazopanib—CYP3A4—urine—bipolar disorder	0.00363	0.00799	CbGeAlD
Pazopanib—CYP2D6—urine—bipolar disorder	0.00357	0.00786	CbGeAlD
Pazopanib—STK36—thyroid gland—bipolar disorder	0.00346	0.00762	CbGeAlD
Pazopanib—PI4KB—thyroid gland—bipolar disorder	0.00341	0.0075	CbGeAlD
Pazopanib—FLT1—adrenal cortex—bipolar disorder	0.00336	0.00739	CbGeAlD
Pazopanib—LIMK2—thyroid gland—bipolar disorder	0.00335	0.00737	CbGeAlD
Pazopanib—STK16—nervous system—bipolar disorder	0.0033	0.00725	CbGeAlD
Pazopanib—LYN—nervous system—bipolar disorder	0.00326	0.00717	CbGeAlD
Pazopanib—FGFR3—nervous system—bipolar disorder	0.00324	0.00714	CbGeAlD
Pazopanib—RIOK2—nervous system—bipolar disorder	0.00324	0.00714	CbGeAlD
Pazopanib—MAP3K19—nervous system—bipolar disorder	0.00321	0.00706	CbGeAlD
Pazopanib—BMPR1B—nervous system—bipolar disorder	0.00321	0.00706	CbGeAlD
Pazopanib—TAOK3—adrenal cortex—bipolar disorder	0.00317	0.00697	CbGeAlD
Pazopanib—TAOK1—brain—bipolar disorder	0.00315	0.00692	CbGeAlD
Pazopanib—STK16—cerebellum—bipolar disorder	0.0031	0.00682	CbGeAlD
Pazopanib—RIOK2—cerebellum—bipolar disorder	0.00305	0.00671	CbGeAlD
Pazopanib—FGFR3—cerebellum—bipolar disorder	0.00305	0.00671	CbGeAlD
Pazopanib—BMPR1B—cerebellum—bipolar disorder	0.00302	0.00665	CbGeAlD
Pazopanib—FLT4—thyroid gland—bipolar disorder	0.00301	0.00662	CbGeAlD
Pazopanib—PIP4K2C—thyroid gland—bipolar disorder	0.00299	0.00658	CbGeAlD
Pazopanib—FGFR1—thyroid gland—bipolar disorder	0.00297	0.00653	CbGeAlD
Pazopanib—SH2B3—brain—bipolar disorder	0.00296	0.00652	CbGeAlD
Pazopanib—AURKC—brain—bipolar disorder	0.00292	0.00641	CbGeAlD
Pazopanib—STK36—nervous system—bipolar disorder	0.00291	0.00641	CbGeAlD
Pazopanib—PI4KB—nervous system—bipolar disorder	0.00287	0.00631	CbGeAlD
Pazopanib—KDR—adrenal cortex—bipolar disorder	0.00284	0.00625	CbGeAlD
Pazopanib—MAP2K5—adrenal cortex—bipolar disorder	0.00284	0.00625	CbGeAlD
Pazopanib—MAP3K2—thyroid gland—bipolar disorder	0.00284	0.00624	CbGeAlD
Pazopanib—LIMK2—nervous system—bipolar disorder	0.00282	0.0062	CbGeAlD
Pazopanib—CYP2C8—blood plasma—bipolar disorder	0.0028	0.00616	CbGeAlD
Pazopanib—CSF1R—adrenal cortex—bipolar disorder	0.00277	0.0061	CbGeAlD
Pazopanib—STK36—cerebellum—bipolar disorder	0.00274	0.00603	CbGeAlD
Pazopanib—PI4KB—cerebellum—bipolar disorder	0.0027	0.00594	CbGeAlD
Pazopanib—FGF1—thyroid gland—bipolar disorder	0.00267	0.00588	CbGeAlD
Pazopanib—PLK4—brain—bipolar disorder	0.00267	0.00587	CbGeAlD
Pazopanib—LCK—thyroid gland—bipolar disorder	0.00266	0.00584	CbGeAlD
Pazopanib—LIMK2—cerebellum—bipolar disorder	0.00265	0.00583	CbGeAlD
Pazopanib—CYP1A2—blood plasma—bipolar disorder	0.00262	0.00576	CbGeAlD
Pazopanib—FGFR2—thyroid gland—bipolar disorder	0.00252	0.00555	CbGeAlD
Pazopanib—STK16—brain—bipolar disorder	0.00252	0.00554	CbGeAlD
Pazopanib—PIP4K2C—nervous system—bipolar disorder	0.00252	0.00554	CbGeAlD
Pazopanib—LYN—brain—bipolar disorder	0.00249	0.00548	CbGeAlD
Pazopanib—FGFR3—brain—bipolar disorder	0.00248	0.00545	CbGeAlD
Pazopanib—RIOK2—brain—bipolar disorder	0.00248	0.00545	CbGeAlD
Pazopanib—PDGFRB—adrenal cortex—bipolar disorder	0.00246	0.00541	CbGeAlD
Pazopanib—MAP3K19—brain—bipolar disorder	0.00245	0.0054	CbGeAlD
Pazopanib—BMPR1B—brain—bipolar disorder	0.00245	0.0054	CbGeAlD
Pazopanib—MAP3K2—nervous system—bipolar disorder	0.00239	0.00525	CbGeAlD
Pazopanib—PIP4K2C—cerebellum—bipolar disorder	0.00237	0.00521	CbGeAlD
Pazopanib—FGFR1—cerebellum—bipolar disorder	0.00235	0.00517	CbGeAlD
Pazopanib—FLT1—thyroid gland—bipolar disorder	0.00234	0.00515	CbGeAlD
Pazopanib—EPHB6—thyroid gland—bipolar disorder	0.00231	0.00509	CbGeAlD
Pazopanib—FGF1—nervous system—bipolar disorder	0.00225	0.00495	CbGeAlD
Pazopanib—MAP3K2—cerebellum—bipolar disorder	0.00225	0.00494	CbGeAlD
Pazopanib—STK36—brain—bipolar disorder	0.00223	0.0049	CbGeAlD
Pazopanib—STK10—thyroid gland—bipolar disorder	0.00222	0.00487	CbGeAlD
Pazopanib—TAOK3—thyroid gland—bipolar disorder	0.00221	0.00485	CbGeAlD
Pazopanib—PI4KB—brain—bipolar disorder	0.00219	0.00482	CbGeAlD
Pazopanib—PDGFRA—thyroid gland—bipolar disorder	0.00219	0.00482	CbGeAlD
Pazopanib—LIMK2—brain—bipolar disorder	0.00215	0.00474	CbGeAlD
Pazopanib—FGFR2—nervous system—bipolar disorder	0.00212	0.00467	CbGeAlD
Pazopanib—FGF1—cerebellum—bipolar disorder	0.00212	0.00465	CbGeAlD
Pazopanib—FGFR2—cerebellum—bipolar disorder	0.002	0.0044	CbGeAlD
Pazopanib—KDR—thyroid gland—bipolar disorder	0.00198	0.00435	CbGeAlD
Pazopanib—MAP2K5—thyroid gland—bipolar disorder	0.00198	0.00435	CbGeAlD
Pazopanib—FLT1—nervous system—bipolar disorder	0.00197	0.00433	CbGeAlD
Pazopanib—EPHB6—nervous system—bipolar disorder	0.00195	0.00428	CbGeAlD
Pazopanib—FLT4—brain—bipolar disorder	0.00193	0.00426	CbGeAlD
Pazopanib—CSF1R—thyroid gland—bipolar disorder	0.00193	0.00425	CbGeAlD
Pazopanib—PIP4K2C—brain—bipolar disorder	0.00192	0.00423	CbGeAlD
Pazopanib—FGFR1—brain—bipolar disorder	0.00191	0.0042	CbGeAlD
Pazopanib—CYP3A4—blood plasma—bipolar disorder	0.0019	0.00417	CbGeAlD
Pazopanib—CYP2D6—blood plasma—bipolar disorder	0.00187	0.0041	CbGeAlD
Pazopanib—STK10—nervous system—bipolar disorder	0.00186	0.0041	CbGeAlD
Pazopanib—TAOK3—nervous system—bipolar disorder	0.00186	0.00408	CbGeAlD
Pazopanib—FLT1—cerebellum—bipolar disorder	0.00185	0.00407	CbGeAlD
Pazopanib—PDGFRA—nervous system—bipolar disorder	0.00184	0.00406	CbGeAlD
Pazopanib—EPHB6—cerebellum—bipolar disorder	0.00183	0.00403	CbGeAlD
Pazopanib—MAP3K2—brain—bipolar disorder	0.00182	0.00401	CbGeAlD
Pazopanib—STK10—cerebellum—bipolar disorder	0.00175	0.00386	CbGeAlD
Pazopanib—KIT—thyroid gland—bipolar disorder	0.00175	0.00386	CbGeAlD
Pazopanib—TAOK3—cerebellum—bipolar disorder	0.00175	0.00384	CbGeAlD
Pazopanib—PDGFRA—cerebellum—bipolar disorder	0.00174	0.00382	CbGeAlD
Pazopanib—FGF1—brain—bipolar disorder	0.00172	0.00378	CbGeAlD
Pazopanib—PDGFRB—thyroid gland—bipolar disorder	0.00171	0.00377	CbGeAlD
Pazopanib—KDR—nervous system—bipolar disorder	0.00166	0.00366	CbGeAlD
Pazopanib—MAP2K5—nervous system—bipolar disorder	0.00166	0.00366	CbGeAlD
Pazopanib—CSF1R—nervous system—bipolar disorder	0.00162	0.00357	CbGeAlD
Pazopanib—FGFR2—brain—bipolar disorder	0.00162	0.00357	CbGeAlD
Pazopanib—KDR—cerebellum—bipolar disorder	0.00157	0.00344	CbGeAlD
Pazopanib—MAP2K5—cerebellum—bipolar disorder	0.00157	0.00344	CbGeAlD
Pazopanib—CSF1R—cerebellum—bipolar disorder	0.00153	0.00336	CbGeAlD
Pazopanib—FLT1—brain—bipolar disorder	0.0015	0.00331	CbGeAlD
Pazopanib—EPHB6—brain—bipolar disorder	0.00149	0.00327	CbGeAlD
Pazopanib—KIT—nervous system—bipolar disorder	0.00147	0.00324	CbGeAlD
Pazopanib—PDGFRB—nervous system—bipolar disorder	0.00144	0.00317	CbGeAlD
Pazopanib—STK10—brain—bipolar disorder	0.00142	0.00313	CbGeAlD
Pazopanib—TAOK3—brain—bipolar disorder	0.00142	0.00312	CbGeAlD
Pazopanib—PDGFRA—brain—bipolar disorder	0.00141	0.0031	CbGeAlD
Pazopanib—KIT—cerebellum—bipolar disorder	0.00139	0.00305	CbGeAlD
Pazopanib—ABCG2—adrenal cortex—bipolar disorder	0.00138	0.00304	CbGeAlD
Pazopanib—PDGFRB—cerebellum—bipolar disorder	0.00136	0.00298	CbGeAlD
Pazopanib—ABCB1—blood plasma—bipolar disorder	0.00134	0.00295	CbGeAlD
Pazopanib—KDR—brain—bipolar disorder	0.00127	0.0028	CbGeAlD
Pazopanib—MAP2K5—brain—bipolar disorder	0.00127	0.0028	CbGeAlD
Pazopanib—CSF1R—brain—bipolar disorder	0.00124	0.00273	CbGeAlD
Pazopanib—KIT—brain—bipolar disorder	0.00113	0.00248	CbGeAlD
Pazopanib—PDGFRB—brain—bipolar disorder	0.0011	0.00242	CbGeAlD
Pazopanib—ABCG2—thyroid gland—bipolar disorder	0.000962	0.00212	CbGeAlD
Pazopanib—CYP1A2—thyroid gland—bipolar disorder	0.000926	0.00204	CbGeAlD
Pazopanib—ABCG2—cerebellum—bipolar disorder	0.000762	0.00168	CbGeAlD
Pazopanib—ABCB1—adrenal cortex—bipolar disorder	0.000681	0.0015	CbGeAlD
Pazopanib—CYP2C8—brain—bipolar disorder	0.000636	0.0014	CbGeAlD
Pazopanib—ABCG2—brain—bipolar disorder	0.000619	0.00136	CbGeAlD
Pazopanib—CYP3A4—nervous system—bipolar disorder	0.000564	0.00124	CbGeAlD
Pazopanib—CYP2D6—nervous system—bipolar disorder	0.000555	0.00122	CbGeAlD
Pazopanib—CYP2D6—cerebellum—bipolar disorder	0.000522	0.00115	CbGeAlD
Pazopanib—ABCB1—thyroid gland—bipolar disorder	0.000475	0.00104	CbGeAlD
Pazopanib—CYP2D6—brain—bipolar disorder	0.000424	0.000933	CbGeAlD
Pazopanib—ABCB1—nervous system—bipolar disorder	0.000399	0.000878	CbGeAlD
Pazopanib—ABCB1—cerebellum—bipolar disorder	0.000376	0.000826	CbGeAlD
Pazopanib—ABCB1—brain—bipolar disorder	0.000305	0.000671	CbGeAlD
Pazopanib—FGF1—Disease—INS—bipolar disorder	4.27e-05	7.82e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—DRD1—bipolar disorder	4.25e-05	7.79e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—HTR2C—bipolar disorder	4.25e-05	7.79e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—AKR1C4—bipolar disorder	4.25e-05	7.79e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TAC1—bipolar disorder	4.24e-05	7.78e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—ADCY2—bipolar disorder	4.19e-05	7.68e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—ADCY2—bipolar disorder	4.18e-05	7.66e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—NRG1—bipolar disorder	4.17e-05	7.65e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TCF7L2—bipolar disorder	4.17e-05	7.65e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—DRD1—bipolar disorder	4.16e-05	7.63e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—HTR2C—bipolar disorder	4.16e-05	7.63e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TCF7L2—bipolar disorder	4.16e-05	7.63e-05	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—IL1B—bipolar disorder	4.15e-05	7.61e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—DRD2—bipolar disorder	4.14e-05	7.6e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—MTHFR—bipolar disorder	4.14e-05	7.59e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NTRK2—bipolar disorder	4.13e-05	7.58e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—DRD2—bipolar disorder	4.13e-05	7.58e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—NRG1—bipolar disorder	4.13e-05	7.57e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—MTHFR—bipolar disorder	4.13e-05	7.57e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—ADCY2—bipolar disorder	4.12e-05	7.56e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—DRD3—bipolar disorder	4.12e-05	7.55e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—GSK3A—bipolar disorder	4.1e-05	7.51e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—S100B—bipolar disorder	4.07e-05	7.46e-05	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	4.07e-05	7.46e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NTRK2—bipolar disorder	4.05e-05	7.42e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—NR1D1—bipolar disorder	4.05e-05	7.42e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—HTR2A—bipolar disorder	4.05e-05	7.42e-05	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	4.04e-05	7.4e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—DRD3—bipolar disorder	4.03e-05	7.39e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—NTRK1—bipolar disorder	4.02e-05	7.38e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—GSK3A—bipolar disorder	4.01e-05	7.36e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—DRD4—bipolar disorder	4e-05	7.33e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—NTRK1—bipolar disorder	3.95e-05	7.25e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—SNAP25—bipolar disorder	3.95e-05	7.25e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—HTR2A—bipolar disorder	3.94e-05	7.23e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—DRD4—bipolar disorder	3.91e-05	7.17e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—S100B—bipolar disorder	3.91e-05	7.17e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—GSK3B—bipolar disorder	3.88e-05	7.11e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—NCAN—bipolar disorder	3.87e-05	7.1e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—S100B—bipolar disorder	3.84e-05	7.04e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—NR1D1—bipolar disorder	3.81e-05	6.99e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—GSK3B—bipolar disorder	3.81e-05	6.98e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—SLC5A3—bipolar disorder	3.79e-05	6.96e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—ADCY2—bipolar disorder	3.78e-05	6.93e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Biological oxidations—POMC—bipolar disorder	3.77e-05	6.91e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—HTR2A—bipolar disorder	3.76e-05	6.9e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—ADCY2—bipolar disorder	3.76e-05	6.9e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—NTRK1—bipolar disorder	3.75e-05	6.88e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TCF7L2—bipolar disorder	3.75e-05	6.87e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—NTRK1—bipolar disorder	3.74e-05	6.86e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—DRD2—bipolar disorder	3.72e-05	6.83e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—MTHFR—bipolar disorder	3.72e-05	6.82e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—NDUFV2—bipolar disorder	3.71e-05	6.81e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—ADCY2—bipolar disorder	3.68e-05	6.75e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TCF7L2—bipolar disorder	3.67e-05	6.73e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—NCAN—bipolar disorder	3.65e-05	6.69e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—S100B—bipolar disorder	3.65e-05	6.69e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—DRD2—bipolar disorder	3.65e-05	6.68e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—GSK3B—bipolar disorder	3.64e-05	6.68e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—S100B—bipolar disorder	3.64e-05	6.67e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—POMC—bipolar disorder	3.62e-05	6.63e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—GSK3B—bipolar disorder	3.61e-05	6.63e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—GSK3B—bipolar disorder	3.6e-05	6.61e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—AKR1C4—bipolar disorder	3.6e-05	6.6e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—INS—bipolar disorder	3.6e-05	6.59e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—NRG1—bipolar disorder	3.59e-05	6.58e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—GSK3B—bipolar disorder	3.58e-05	6.56e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—SLC5A3—bipolar disorder	3.57e-05	6.55e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HTR1A—bipolar disorder	3.53e-05	6.48e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—INS—bipolar disorder	3.53e-05	6.47e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—COMT—bipolar disorder	3.53e-05	6.47e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—GSK3B—bipolar disorder	3.52e-05	6.45e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—MAOA—bipolar disorder	3.5e-05	6.43e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—ADCY2—bipolar disorder	3.5e-05	6.41e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TAC1—bipolar disorder	3.48e-05	6.38e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—INS—bipolar disorder	3.47e-05	6.36e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—NRG1—bipolar disorder	3.45e-05	6.33e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL1B—bipolar disorder	3.45e-05	6.32e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HTR2C—bipolar disorder	3.41e-05	6.25e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—DRD1—bipolar disorder	3.41e-05	6.25e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—NRG1—bipolar disorder	3.39e-05	6.22e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—IMPA1—bipolar disorder	3.37e-05	6.18e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NTRK1—bipolar disorder	3.37e-05	6.18e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—GSK3B—bipolar disorder	3.34e-05	6.12e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—GSK3B—bipolar disorder	3.33e-05	6.1e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NTRK2—bipolar disorder	3.32e-05	6.08e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—NRG1—bipolar disorder	3.31e-05	6.08e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—DRD3—bipolar disorder	3.3e-05	6.06e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NTRK1—bipolar disorder	3.3e-05	6.05e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—INS—bipolar disorder	3.29e-05	6.03e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—GSK3A—bipolar disorder	3.29e-05	6.03e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—INS—bipolar disorder	3.28e-05	6.02e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—S100B—bipolar disorder	3.28e-05	6.01e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—GSK3B—bipolar disorder	3.26e-05	5.97e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—GSK3B—bipolar disorder	3.25e-05	5.95e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—COMT—bipolar disorder	3.23e-05	5.93e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—NR1D1—bipolar disorder	3.23e-05	5.93e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—POMC—bipolar disorder	3.23e-05	5.93e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—NRG1—bipolar disorder	3.22e-05	5.9e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—INS—bipolar disorder	3.21e-05	5.89e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—MAOA—bipolar disorder	3.21e-05	5.89e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—NRG1—bipolar disorder	3.21e-05	5.89e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—S100B—bipolar disorder	3.21e-05	5.88e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—DRD4—bipolar disorder	3.21e-05	5.88e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—GSK3B—bipolar disorder	3.18e-05	5.83e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—GSK3B—bipolar disorder	3.17e-05	5.82e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—POMC—bipolar disorder	3.15e-05	5.77e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CLOCK—bipolar disorder	3.15e-05	5.77e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—INS—bipolar disorder	3.13e-05	5.74e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—HTR2A—bipolar disorder	3.11e-05	5.71e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—NCAN—bipolar disorder	3.09e-05	5.67e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CACNB2—bipolar disorder	3.07e-05	5.62e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—TPH2—bipolar disorder	3.07e-05	5.62e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—TSHB—bipolar disorder	3.07e-05	5.62e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—HTR2A—bipolar disorder	3.06e-05	5.61e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—GSK3B—bipolar disorder	3.03e-05	5.55e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—SLC5A3—bipolar disorder	3.03e-05	5.55e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—ADCY2—bipolar disorder	3.02e-05	5.54e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—DPYD—bipolar disorder	3.02e-05	5.53e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TCF7L2—bipolar disorder	3.01e-05	5.52e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—POMC—bipolar disorder	3e-05	5.51e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—GSK3B—bipolar disorder	3e-05	5.5e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—COMT—bipolar disorder	3e-05	5.49e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—INS—bipolar disorder	2.99e-05	5.48e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—DRD2—bipolar disorder	2.99e-05	5.48e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—MTHFR—bipolar disorder	2.98e-05	5.47e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—MAOA—bipolar disorder	2.97e-05	5.45e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—INS—bipolar disorder	2.96e-05	5.42e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—HTR2A—bipolar disorder	2.9e-05	5.32e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—HTR2A—bipolar disorder	2.89e-05	5.31e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NRG1—bipolar disorder	2.89e-05	5.3e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NDUFV2—bipolar disorder	2.87e-05	5.26e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL1B—bipolar disorder	2.85e-05	5.23e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—MTHFR—bipolar disorder	2.85e-05	5.23e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NRG1—bipolar disorder	2.83e-05	5.19e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CACNA1C—bipolar disorder	2.81e-05	5.14e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL1B—bipolar disorder	2.8e-05	5.14e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—AKR1C4—bipolar disorder	2.78e-05	5.09e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CLOCK—bipolar disorder	2.74e-05	5.03e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PIK3C2A—bipolar disorder	2.73e-05	5.01e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NTRK1—bipolar disorder	2.71e-05	4.96e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	2.7e-05	4.95e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—TSHB—bipolar disorder	2.67e-05	4.9e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—TPH2—bipolar disorder	2.67e-05	4.9e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CACNB2—bipolar disorder	2.67e-05	4.9e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL1B—bipolar disorder	2.66e-05	4.88e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL1B—bipolar disorder	2.65e-05	4.86e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—S100B—bipolar disorder	2.63e-05	4.82e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—DPYD—bipolar disorder	2.63e-05	4.82e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—MTHFR—bipolar disorder	2.61e-05	4.79e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—HTR2A—bipolar disorder	2.61e-05	4.78e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—GSK3B—bipolar disorder	2.61e-05	4.78e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CLOCK—bipolar disorder	2.58e-05	4.74e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—HTR2A—bipolar disorder	2.55e-05	4.68e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—TSHB—bipolar disorder	2.52e-05	4.62e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—TPH2—bipolar disorder	2.52e-05	4.62e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CACNB2—bipolar disorder	2.52e-05	4.62e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—GSK3B—bipolar disorder	2.51e-05	4.6e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NR1D1—bipolar disorder	2.49e-05	4.57e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—POMC—bipolar disorder	2.49e-05	4.56e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—DPYD—bipolar disorder	2.48e-05	4.54e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—INS—bipolar disorder	2.47e-05	4.53e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—GSK3B—bipolar disorder	2.46e-05	4.51e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—SNAP25—bipolar disorder	2.45e-05	4.5e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CACNA1C—bipolar disorder	2.44e-05	4.48e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—POMC—bipolar disorder	2.44e-05	4.48e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—INS—bipolar disorder	2.43e-05	4.45e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—MTHFR—bipolar disorder	2.42e-05	4.44e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—GSK3B—bipolar disorder	2.41e-05	4.41e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL1B—bipolar disorder	2.39e-05	4.38e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NCAN—bipolar disorder	2.39e-05	4.37e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PIK3C2A—bipolar disorder	2.38e-05	4.37e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—INS—bipolar disorder	2.37e-05	4.35e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL1B—bipolar disorder	2.34e-05	4.29e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—SLC5A3—bipolar disorder	2.34e-05	4.29e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—GSK3B—bipolar disorder	2.34e-05	4.28e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—GSK3B—bipolar disorder	2.33e-05	4.27e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NRG1—bipolar disorder	2.32e-05	4.26e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—POMC—bipolar disorder	2.32e-05	4.25e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—POMC—bipolar disorder	2.31e-05	4.24e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—INS—bipolar disorder	2.3e-05	4.23e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CACNA1C—bipolar disorder	2.3e-05	4.22e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—INS—bipolar disorder	2.3e-05	4.21e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—POMC—bipolar disorder	2.28e-05	4.18e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—INS—bipolar disorder	2.27e-05	4.16e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	2.24e-05	4.12e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CLOCK—bipolar disorder	2.19e-05	4.01e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ADCY2—bipolar disorder	2.17e-05	3.98e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—SNAP25—bipolar disorder	2.14e-05	3.92e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—TSHB—bipolar disorder	2.13e-05	3.91e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—TPH2—bipolar disorder	2.13e-05	3.91e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CACNB2—bipolar disorder	2.13e-05	3.91e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—GSK3B—bipolar disorder	2.1e-05	3.85e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—DPYD—bipolar disorder	2.1e-05	3.85e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HTR2A—bipolar disorder	2.09e-05	3.84e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—POMC—bipolar disorder	2.09e-05	3.83e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—POMC—bipolar disorder	2.08e-05	3.82e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—INS—bipolar disorder	2.08e-05	3.81e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—INS—bipolar disorder	2.07e-05	3.8e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—GSK3B—bipolar disorder	2.06e-05	3.77e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—POMC—bipolar disorder	2.04e-05	3.74e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—INS—bipolar disorder	2.03e-05	3.72e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—SNAP25—bipolar disorder	2.01e-05	3.69e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CACNA1C—bipolar disorder	1.95e-05	3.58e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—POMC—bipolar disorder	1.94e-05	3.55e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—INS—bipolar disorder	1.93e-05	3.53e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL1B—bipolar disorder	1.92e-05	3.52e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	1.9e-05	3.49e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ADCY2—bipolar disorder	1.89e-05	3.47e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	1.88e-05	3.44e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—COMT—bipolar disorder	1.86e-05	3.41e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—MAOA—bipolar disorder	1.85e-05	3.38e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ADCY2—bipolar disorder	1.78e-05	3.27e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—SNAP25—bipolar disorder	1.71e-05	3.13e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CLOCK—bipolar disorder	1.69e-05	3.1e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—GSK3B—bipolar disorder	1.68e-05	3.09e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—POMC—bipolar disorder	1.67e-05	3.06e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—INS—bipolar disorder	1.66e-05	3.05e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CACNB2—bipolar disorder	1.65e-05	3.02e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—TPH2—bipolar disorder	1.65e-05	3.02e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—TSHB—bipolar disorder	1.65e-05	3.02e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—DPYD—bipolar disorder	1.62e-05	2.97e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—COMT—bipolar disorder	1.62e-05	2.97e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—MAOA—bipolar disorder	1.61e-05	2.95e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—COMT—bipolar disorder	1.53e-05	2.8e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—MAOA—bipolar disorder	1.52e-05	2.78e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ADCY2—bipolar disorder	1.51e-05	2.77e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CACNA1C—bipolar disorder	1.51e-05	2.76e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—MTHFR—bipolar disorder	1.5e-05	2.75e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	1.47e-05	2.69e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—SNAP25—bipolar disorder	1.32e-05	2.41e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—MTHFR—bipolar disorder	1.31e-05	2.4e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—COMT—bipolar disorder	1.29e-05	2.37e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—MAOA—bipolar disorder	1.28e-05	2.35e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—MTHFR—bipolar disorder	1.23e-05	2.26e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—POMC—bipolar disorder	1.2e-05	2.2e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—INS—bipolar disorder	1.19e-05	2.19e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ADCY2—bipolar disorder	1.17e-05	2.14e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—POMC—bipolar disorder	1.05e-05	1.92e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—MTHFR—bipolar disorder	1.04e-05	1.92e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—INS—bipolar disorder	1.04e-05	1.91e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—COMT—bipolar disorder	9.98e-06	1.83e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—MAOA—bipolar disorder	9.91e-06	1.82e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—POMC—bipolar disorder	9.86e-06	1.81e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—INS—bipolar disorder	9.81e-06	1.8e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—POMC—bipolar disorder	8.36e-06	1.53e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—INS—bipolar disorder	8.31e-06	1.52e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—MTHFR—bipolar disorder	8.06e-06	1.48e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—POMC—bipolar disorder	6.45e-06	1.18e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—INS—bipolar disorder	6.41e-06	1.18e-05	CbGpPWpGaD
